Diana Katharine Hunt

This inventor holds 7 USPTO granted patents and 10 published patent applications, plus 3 CIPO patents and 6 EPO patents. Top assignee: Tetraphase Pharmaceuticals, Inc.. Active years: 2013-2021.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Diana Katharine Hunt. Retrieved from https://idiyas.com/inventor/diana-katharine-hunt

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 7 (Patent Applications = 10)

% Patents Active = 85.7

CIPO Patents = 3

EPO Patents = 6 (Patent Applications = 5)

Average Co-Inventor Count = 6.6

ph-index = 5

Forward Citations = 51(Granted Patents)

Company Filing History:

7 out of 18

Tetraphase Pharmaceuticals, Inc.

patents

Years Active: 2013-2021

Loading Chart...

7 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 10913712 - Tetracycline compounds (2021-02-09),

2. 10315992 - Tetracyline compounds (2019-06-11),

3. 9573895 - Tetracycline compounds (2017-02-21),

4. 9371283 - Polycyclic tetracycline compounds (2016-06-21),

5. 8906887 - C7-fluoro substituted tetracycline compounds (2014-12-09),

6. 8796245 - C7-fluoro substituted tetracycline compounds (2014-08-05),

7. 8501716 - C7-fluoro substituted tetracycline compounds (2013-08-06),

Title: Diana Katharine Hunt: Innovator in Pharmaceutical Compounds

Introduction

Diana Katharine Hunt is a prominent inventor based in Cambridge, MA (US). She has made significant contributions to the field of pharmaceuticals, particularly in the development of tetracycline compounds. With a total of seven patents to her name, her work has had a substantial impact on medical science.

Latest Patents

Among her latest patents, Diana has focused on tetracycline compounds. The present invention is directed to a compound represented by Structural Formula (I) or a pharmaceutically acceptable salt thereof. The variables for Structural Formula (I) are defined within the patent documentation. Additionally, she has described a pharmaceutical composition comprising the compound of Structural Formula (I) and its therapeutic use.

Career Highlights

Diana is currently associated with Tetraphase Pharmaceuticals, Inc., where she continues to innovate and develop new pharmaceutical solutions. Her expertise in the field has led to advancements that benefit both healthcare providers and patients.

Collaborations

Throughout her career, Diana has collaborated with notable colleagues, including Xiao-Yi Xiao and Roger B Clark. These partnerships have fostered a collaborative environment that enhances the research and development process.

Conclusion

Diana Katharine Hunt is a distinguished inventor whose work in tetracycline compounds exemplifies innovation in the pharmaceutical industry. Her contributions continue to shape the future of medical treatments and

Profile summary based on public USPTO records.